Page 1 of Clinical Trials for ( Tibotec Therapeutics AND a Division of Ortho Biotech Products AND L.P. AND USA ) [SPONSOR-COLLABORATORS], 14 Total Matches
- 1CompletedLast Updated: January 13, 2011Condition(s): HIV Infections; Infection
- 2Active, not recruitingLast Updated: May 15, 2012Condition(s): HIV
- 3CompletedLast Updated: December 30, 2010Condition(s): HIV Infections
- 4CompletedLast Updated: November 30, 2011Condition(s): HIV
- 5CompletedLast Updated: October 18, 2010Condition(s): HIV-1 Infection
- 6Active, not recruiting
- 7Not yet recruitingLast Updated: January 10, 2012Condition(s): HIV
- 8CompletedLast Updated: June 8, 2011Condition(s): Multiple Myeloma; Myeloma; M-Protein; Myeloma Proteins
- 9RecruitingLast Updated: March 6, 2008Condition(s): HIV Infections; Hyperlipidemia
- 10CompletedLast Updated: January 5, 2011Condition(s): Endothelial Function; Lipids; Insulin Resistance; Inflammation; HIV Infections
- 11CompletedLast Updated: January 10, 2008Condition(s): Cancer; Carcinoma
- 12Active, not recruitingLast Updated: October 6, 2011Condition(s): HIV Infection
- 13CompletedLast Updated: October 18, 2010Condition(s): Multiple Myeloma; Cancer
- 14TerminatedDOXIL vs. Xeloda as First Line Chemotherapy for Metastatic Breast Cancer in Women 60 Years and OlderLast Updated: June 8, 2011Condition(s): Breast Neoplasms; Breast Cancer; Cancer of Breast; Cancer of the Breast
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Tibotec+Therapeutics%2C+a+Division+of+Ortho+Biotech+Products%2C+L.P.%2C+USA
